Clinical study of an extended-patency dialysis access graft

Ended Project Grant Awarded Last action

Award ID
R44DK116380
Recipient
Awarding agency
Obligated
$440,339

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Originally
Place of performance
Seattle, WA 98103, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Clinical study of an extended-patency dialysis access graft project summary objective: the goals of this PAR-17-034 "clinical studies fast-track" sbir… $0
Amendment $0
Amendment $440,339
Amendment -$440,339
Original award $440,339

Quick answers

Who received award R44DK116380?

R44DK116380 was awarded to Healionics Corporation by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2017.

How much is award R44DK116380 worth?

$440,339 has been obligated on R44DK116380.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award